Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Clinical and biological role of secretory phospholipase A2 in acute respiratory distress syndrome infants.

De Luca D, Lopez-Rodriguez E, Minucci A, Vendittelli F, Gentile L, Stival E, Conti G, Piastra M, Antonelli M, Echaide M, Perez-Gil J, Capoluongo ED.

Crit Care. 2013 Jul 24;17(4):R163. doi: 10.1186/cc12842.

2.

Ex vivo effect of varespladib on secretory phospholipase A2 alveolar activity in infants with ARDS.

De Luca D, Minucci A, Piastra M, Cogo PE, Vendittelli F, Marzano L, Gentile L, Giardina B, Conti G, Capoluongo ED.

PLoS One. 2012;7(10):e47066. doi: 10.1371/journal.pone.0047066. Epub 2012 Oct 11.

3.

Secretory phospholipase A2-mediated depletion of phosphatidylglycerol in early acute respiratory distress syndrome.

Seeds MC, Grier BL, Suckling BN, Safta AM, Long DL, Waite BM, Morris PE, Hite RD.

Am J Med Sci. 2012 Jun;343(6):446-51. doi: 10.1097/MAJ.0b013e318239c96c.

4.

Secretory phospholipase A₂ pathway during pediatric acute respiratory distress syndrome: a preliminary study.

De Luca D, Minucci A, Cogo P, Capoluongo ED, Conti G, Pietrini D, Carnielli VP, Piastra M.

Pediatr Crit Care Med. 2011 Jan;12(1):e20-4. doi: 10.1097/PCC.0b013e3181dbe95e.

PMID:
20351613
5.

Secretory phospholipase A2 and neonatal respiratory distress: pilot study on broncho-alveolar lavage.

De Luca D, Baroni S, Vento G, Piastra M, Pietrini D, Romitelli F, Capoluongo E, Romagnoli C, Conti G, Zecca E.

Intensive Care Med. 2008 Oct;34(10):1858-64. doi: 10.1007/s00134-008-1224-3. Epub 2008 Jul 22.

PMID:
18648767
6.

Bile acids cause secretory phospholipase A2 activity enhancement, revertible by exogenous surfactant administration.

De Luca D, Minucci A, Zecca E, Piastra M, Pietrini D, Carnielli VP, Zuppi C, Tridente A, Conti G, Capoluongo ED.

Intensive Care Med. 2009 Feb;35(2):321-6. doi: 10.1007/s00134-008-1321-3. Epub 2008 Oct 14.

PMID:
18853138
7.

Varespladib inhibits secretory phospholipase A2 in bronchoalveolar lavage of different types of neonatal lung injury.

De Luca D, Minucci A, Trias J, Tripodi D, Conti G, Zuppi C, Capoluongo E; Study Group on Secretory Phospholipase in Pediatrics..

J Clin Pharmacol. 2012 May;52(5):729-37. doi: 10.1177/0091270011405498. Epub 2011 May 20.

PMID:
21602519
8.

Increased phospholipase A2 and lyso-phosphatidylcholine levels are associated with surfactant dysfunction in lung contusion injury in mice.

Machado-Aranda D, Wang Z, Yu B, Suresh MV, Notter RH, Raghavendran K.

Surgery. 2013 Jan;153(1):25-35. doi: 10.1016/j.surg.2012.05.043. Epub 2012 Jul 31.

9.

Phospholipases A2 and platelet-activating-factor acetylhydrolase in patients with acute respiratory distress syndrome.

Nakos G, Kitsiouli E, Hatzidaki E, Koulouras V, Touqui L, Lekka ME.

Crit Care Med. 2005 Apr;33(4):772-9.

PMID:
15818104
10.

Effect of prenatal steroidal inhibition of sPLA2 in a rat model of preterm lung.

Remesal A, De Luca D, San Feliciano L, Isidoro-Garcia M, Minucci A, Pocino K, Casas J, Fabrias G, Capoluongo ED, de la Cruz DL.

Pulm Pharmacol Ther. 2016 Feb;36:31-6. doi: 10.1016/j.pupt.2015.12.001. Epub 2015 Dec 17.

PMID:
26704083
11.

Alveolar fluid in acute respiratory distress syndrome promotes fibroblast migration: role of platelet-derived growth factor pathway*.

Piednoir P, Quesnel C, Nardelli L, Leçon V, Bouadma L, Lasocki S, Philip I, Mailleux A, Soler P, Crestani B, Dehoux M.

Crit Care Med. 2012 Jul;40(7):2041-9. doi: 10.1097/CCM.0b013e31824e65ba.

PMID:
22713216
12.

Pulmonary secretory phospholipase A2 in infants with respiratory distress syndrome stimulates in vitro neutrophil migration.

Schrama AJ, Elferink JG, Hack CE, de Beaufort AJ, Berger HM, Walther FJ.

Neonatology. 2010;97(1):1-9. doi: 10.1159/000220766. Epub 2009 May 27.

PMID:
19478531
13.

Bronchoscopic administration of bovine natural surfactant in ARDS and septic shock: impact on biophysical and biochemical surfactant properties.

Günther A, Schmidt R, Harodt J, Schmehl T, Walmrath D, Ruppert C, Grimminger F, Seeger W.

Eur Respir J. 2002 May;19(5):797-804.

14.

Role of distinct phospholipases A2 and their modulators in meconium aspiration syndrome in human neonates.

De Luca D, Minucci A, Tripodi D, Piastra M, Pietrini D, Zuppi C, Conti G, Carnielli VP, Capoluongo E.

Intensive Care Med. 2011 Jul;37(7):1158-65. doi: 10.1007/s00134-011-2243-z. Epub 2011 May 13.

PMID:
21567110
15.

Phospholipase A2 is present in meconium and inhibits the activity of pulmonary surfactant: an in vitro study.

Schrama AJ, de Beaufort AJ, Sukul YR, Jansen SM, Poorthuis BJ, Berger HM.

Acta Paediatr. 2001 Apr;90(4):412-6.

PMID:
11332933
16.

Early elevation of matrix metalloproteinase-8 and -9 in pediatric ARDS is associated with an increased risk of prolonged mechanical ventilation.

Kong MY, Li Y, Oster R, Gaggar A, Clancy JP.

PLoS One. 2011;6(8):e22596. doi: 10.1371/journal.pone.0022596. Epub 2011 Aug 3.

17.

Secretory phospholipase A2 pathway in various types of lung injury in neonates and infants: a multicentre translational study.

De Luca D, Capoluongo E, Rigo V; Study group on Secretory Phospholipase in Paediatrics (SSPP)..

BMC Pediatr. 2011 Nov 8;11:101. doi: 10.1186/1471-2431-11-101.

18.

Potential role of Clara cell protein, an endogenous phospholipase A2 inhibitor, in acute lung injury.

Jorens PG, Sibille Y, Goulding NJ, van Overveld FJ, Herman AG, Bossaert L, De Backer WA, Lauwerys R, Flower RJ, Bernard A.

Eur Respir J. 1995 Oct;8(10):1647-53.

19.

Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema.

Günther A, Siebert C, Schmidt R, Ziegler S, Grimminger F, Yabut M, Temmesfeld B, Walmrath D, Morr H, Seeger W.

Am J Respir Crit Care Med. 1996 Jan;153(1):176-84.

PMID:
8542113
20.

Infections and the inflammatory response in acute respiratory distress syndrome.

Headley AS, Tolley E, Meduri GU.

Chest. 1997 May;111(5):1306-21.

PMID:
9149588

Supplemental Content

Support Center